Brief: Ascendis Pharma A/S Reports Full Year 2018 Financial Results
Ascendis Pharma A/S ASND.O :
* ASCENDIS PHARMA A/S REPORTS FULL YEAR 2018 FINANCIAL
RESULTS
* ASCENDIS PHARMA A/S - AS OF DEC 31, 2018, HAD CASH AND
CASH
EQUIVALENTS OF EUR 277.9 MILLION VERSUS EUR 195.4 MILLION IN
PRIOR YEAR PERIOD
Source text for Eikon: ID:nGNX564tJH
Further company coverage: ASND.O
Recent news on Ascendis Pharma A/S
See all newsAscendis Pharma tumbles on Novo Nordisk collab termination
BioMarin climbs on global patent settlement with Ascendis
Brief: Ascendis Announces Oral Presentation Of Week 104 Data From Its Pivotal Trial Of Transcon® CNP (Navepegritide) At Isds 2026
Brief: Eyconis Announces Initiation Of First-In-Human Clinical Trial Of Eyc-0305 In Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Ascendis Pharma A/S reports results for the quarter ended June 30 - Earnings Summary